ClinicalTrials.Veeva

Menu

Combination of Parasternal and Serratus Anterior Plane Block in Coronary Artery Bypass Graft Surgery

A

Ankara City Hospital

Status

Completed

Conditions

Cardiac Surgery
Postoperative Analgesia
Parasternal Block
Acute Pain
Serratus Anterior Plane Block

Treatments

Procedure: Combined parasternal block and serratus anterior plane block

Study type

Interventional

Funder types

Other

Identifiers

NCT06326333
E.Kurul-E2-24-6176

Details and patient eligibility

About

Postoperative analgesia is a critical risk factor for the development of pulmonary and cardiovascular complications in coronary artery bypass graft (CABG) surgery. If patients with high pain levels cannot breathe effectively, it may lead to atelectasis, cardiac ischemia, and arrhythmias. This prolongs the time it takes for patients to be discharged and increases the frequency of postoperative pulmonary complications and postoperative morbidity.

In addition to intravenous medications, various neuraxial and peripheral nerve blocks can be used in cardiac surgery. In recent years, neuraxial anesthesia has been avoided due to the use of intraoperative high-dose heparin. As an alternative, peripheral nerve blocks have recently gained popularity. Parasternal block (PSB) and serratus anterior plane block (SAPB) are very superficial and easy to reach. Recently, in the literature, the number of cases performed with these blocks under ultrasound guidance and the number of randomized controlled prospective studies have increased.

With this study, it was aimed to observe the analgesic effects on both the sternum and the drain site by applying PSB and SAPB applications simultaneously in the postoperative analgesia of CABG patients.

Enrollment

20 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 to 80 years old
  • American Society of Anesthesiologists (ASA) physical status I-II-III
  • BMI 18 to 30 kg/m2
  • Elective coronary artery bypass graft (CABG) surgery

Exclusion criteria

  • Patient refusing the procedure
  • Emergency surgery
  • History of chronic opioid or analgesic used

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Combined parasternal block and serratus anterior plane block
Other group
Description:
In the parasternal block application, the needle will be advanced under the pectoralis major muscle and above the intercostal muscle with the ultrasound-guided in-plane technique. 7.5 ml of 0.25% bupivacaine will be injected into this area per each level, at the level of the second and fourth intercostal space. Then, in the serratus anterior plane block application, in the anterior axillary line, the needle will be advanced under the serratus anterior muscle, above the sixth rib, with the in-plane technique under ultrasound guidance. 10 ml of 0.25% bupivacaine will be injected into this area. The application will be applied bilaterally.
Treatment:
Procedure: Combined parasternal block and serratus anterior plane block

Trial contacts and locations

1

Loading...

Central trial contact

Emine Nilgün N Zengin, MD; Aslı Demir, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems